Literatur
-
1
Alpert J S, Thygesen K, Antman E, Bassand J P.
Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
J Am Coll Cardiol.
2000;
36
959-969
-
2
Antman E M, Cohen M, Radley D, McCabe C, Rush J, Premmereur J, Braunwald E.
Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis.
Circulation.
1999;
100
1602-8
-
3
Bertrand M, Simoons M, Keith A A, Wallentin C, Hamm C, McFadden E, De Feyter P, Specchia G, Ruzyllo W.
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Eur Heart J.
2002;
23
1809-1840
-
4
Blake G J, Ridker P M.
C-reactive protein and other inflammatory risk markers in acute coronary syndromes.
J Am Coll Cardiol.
2003;
41
37S-42S
(Suppl 4 S)
-
5
Boersma E, Harrington R A, Moliterno D J, White H, Theroux P, Van de Werf F, de Torbal A, Armstrong P W, Wallentin L C, Wilcox R G, Simes J, Califf R M, Topol E J, Simoons M L.
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Lancet.
2002;
359
189-198
-
6 Braunwald E, Antman E M, Beasley J W, Califf R M, Cheitlin M D, Hochman J S, Jones R H, Kereiakes D, Kupersmith J, Levin T N, Pepine C J, Schaeffer J W, Smith E E III, Steward D E, Theroux P. ACC/AHA 2002 guideline updyocarate for the management of patients with unstable angina and non-ST-segment elevation mdial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdf 2002
-
7
Braunwald E.
Unstable angina. A classification.
Circulation.
1989;
80
410-414
-
8
Cannon C P, Weintraub W S, Demopoulos L A, Vicari R, Frey M J, Lakkis N, Neumann F J, Robertson D H, DeLucca P T, DiBattiste P M, Gibson C M, Braunwald E.
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
N Engl J Med.
2001;
344
1879-1887
-
9
CAPRIE Steering Committee .
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).
Lancet.
1996;3;
48
1329-1339
-
10
Dietz R, Rauch B.
Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung (DGK) in Kooperation mit der Deutschen Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen (DGPR) und der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie (DGTHG).
Z Kardiol.
2003;
92
501-521
-
11
Eikelboom J W, Anand S S, Malmberg K, Weitz J I, Ginsberg J S, Yusuf S.
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.
Lancet.
2000;
355
1936-1942
-
12
Feil H.
Prelimimnary pain in coronary thrombosis.
Am J Med Sci.
1937;
193
42-48
-
13
Fowler N O.
„Preinfarctional” angina: A need for an objective definition and for a controlled trial of its management.
Circulation.
1971;
44
755-758
-
14
Fox K A, Poole-Wilson P A, Henderson R A, Clayton T C, Chamberlain D A, Shaw T R, Wheatley D J, Pocock S J.
Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial.
ancet.
2002;
360
743-751
-
15
FRISC II Investigators .
Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.
Lancet.
1999;
354
708-715
-
16
GUSTO Investigators .
A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators.
N Engl J Med.
1996;
335
775-782
-
17
Hamm C W, Goldmann B, Heeschen C, Kreymann G, Berger J, Meinertz T.
Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I.
N Engl J Med.
1997;
337
1648-1653
-
18
Hamm C W, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, Goldmann B, Katus H A.
The prognostic value of serum troponin T in unstable angina.
N Engl J Med.
1992;
327
146-150
-
19
Hamm C W, Braunwald E.
A classification of unstable angina revisited.
Circulation.
2000;
102
118-122
-
20
Mehta S R, Yusuf S, Peters R J, Bertrand M E, Lewis B S, Natarajan M K, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox K A.
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
Lancet.
2001;
358
527-533
-
21
OASIS Investigators .
Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.
J Am Coll Cardiol.
2001;
37
475-484
-
22
OASIS Investigators .
Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet.
1999;
353
429-438
-
23
Oler A, Whooley M A, Oler J, Grady D.
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.
JAMA.
1996;
276
811-815
-
24
Ridker P M, Rifai N, Clearfield M, Downs J R, Weis S E, Miles J S, Gotto A M, Phil D. for the Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators .
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events.
N Engl J Med.
2001;
344
1959-1965
-
25
Pfeffer M A, Braunwald E, Moye L A, Basta L, Brown E J, Cuddy T E, Davis B R, Geltman E M, Goldman S, Flaker G C. et al .
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
N Engl J Med.
1992;
327
669-677
-
26
Sampson J J, Eliaser M.
The diagnosis of impending acute coronary artery occlusion.
Am Heart J.
1937;
13
675-686
-
27
Scheller B, Hennen B, Böhm M, Nickenig G.
Bedeutung von GPIIb/IIIa-Rezeptor-Antagonisten in der invasiven Kardiologie.
Dtsch Med Wochenschr.
2003;
128
281-287
-
28
Simoons M L.
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.
Lancet.
2001;
357
1915-1924
-
29
Steinhubl S R, Berger P, Mann J T, Fry E T, DeLago A, Wilmer C, Topol E J.
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
JAMA.
2002;
288
2411-2420
-
30
The Heart Outcomes Prevention Evaluation Study Investigators .
Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients.
N Engl J Med.
2000;
342
145-153
-
31
TIMI IIIb Investigators .
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
Circulation.
1994;
89
1545-1556
-
32
Topol E J, Moliterno D J, Herrmann H C, Powers E R, Grines C L, Cohen D J, Cohen E A, Bertrand M, Neumann F J, Stone G W, DiBattiste P M, Demopoulos L.
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
N Engl J Med.
2001;
344
1888-1894
-
33
Trialists`Collaboration .
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
BMJ.
2002;
324
71-86
-
34
Wearn J T.
Thrombosis of the coronary arteries, with infarction of the heart.
Am J Med Sci.
1923;
165
250-276
-
35
Yusuf S, Pepine C J, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B.
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.
Lancet.
1992;
340
1173-1178
-
36
Yusuf S, Zhao F, Mehta S R, Chrolavicius S, Tognoni G, Fox K K.
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
Engl J Med.
2001;
345
494-502
Dr. med. Michael Weber
Abteilung für Kardiologie, Kerckhoff Klinik
Benekestraße 2-8
61231 Bad Nauheim
Email: Michael.Weber@kerckhoff.med.uni-giessen.de
